decrypt8h
Landmark Study Reveals New Benefits and Risks of Obesity Drugs Like Ozempic
A study by the Department of Veterans Affairs says that drugs like Ozempic can do plenty more than just help with weight loss ...
Healthy Returns: Biotech and pharma M&A is off to a good start in 2025 — but will it last?
Biotech and pharma dealmaking is off to a good start in 2025. Meanwhile, digital health fundraising defined by “David and ...
Big Brother’s Aisleyne ‘nearly died’ and ‘looked like a deflated balloon’ after taking fake Ozempic to lose two stone
BIG Brother’s Aisleyne Horgan-Wallace has issued a stark warning after she “nearly died” when she took fake Ozempic to lose two stone. The reality star – who shot to fame ...
What’s behind the meteoric rise of weight-loss drugs in Massachusetts?
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
Novo, Lilly Weight-Loss Drugs Reduce Risk of Alzheimer’s, Study Shows. What It Means for the Stocks.
Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed.The ...
‘Miracle' drug innovation could see a new Wegovy launch every couple of years, Larry Summer says
Miracle drug innovations — such as those that sparked the meteoric rise of Wegovy and Zepbound — could come every couple of years thanks to technology, former U.S. Treasury Secretary Larry Summers ...
Aisleyne Horgan-Wallace says she almost DIED after buying counterfeit Ozempic on the black market while 'in a dark place' following the death of her closest friend
The former Big Brother contestant turned to the controversial weight loss jab after gaining two stone in weight following the ...
PMLiVE15h
Novo shares promising results for high-dose semaglutide in late-stage obesity study
Novo Nordisk has shared positive headline results from a late-stage study evaluating a higher dose of its GLP-1 receptor ...
biznews.com16h
🔒 FT: Weight-loss drugs reduce risk of Alzheimer’s, large study shows
A study shows GLP-1 weight-loss drugs reduce Alzheimer’s risk but increase arthritis, kidney, and pancreas issues.
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
The race for the next Ozempic is on
Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to ...